Keio Univ. to Begin PI Trials of New Drugs for Refractory Immunological Diseases in FY2012

September 5, 2011
Keio University School of Medicine, which has been selected for a government-supported program to create “bases for early-stage and exploratory clinical research” for first-in-human clinical trials, will initiate in FY2012 a first-in-human PI clinical trial to develop a new drug...read more